NCT01754844View on ClinicalTrials.gov

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

AZD7624

Single dose inhaled IMP via a nebulizer

DRUG

Placebo to match

Single dose inhaled Placebo via a nebulizer

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY